Hyperbilirubinemia with Unusual Dermatologic Signs: A Diagnostic Puzzle

Authors

  • Supriono Supriono Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya/Dr. Saiful Anwar General Hospital, Malang http://orcid.org/0000-0002-6368-3983
  • Zahra Safira Internal Medicine Resident, Faculty of Medicine Universitas Brawijaya/Dr. Saiful Anwar General Hospital, Malang.
  • Andika Agus Budiarto Muhammadiyah Lamongan Hospital, Lamongan
  • Mochamad Fachrureza Gastroenterohepatology Subspecialty Education, Faculty of Medicine, Universitas Brawijaya/Dr. Saiful Anwar General Hospital, Malang
  • Syifa Mustika Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya/Dr. Saiful Anwar General Hospital, Malang
  • Bogi Pratomo Wibowo Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya/Dr. Saiful Anwar General Hospital, Malang

Keywords:

cutaneous manifestations, hyperbilirubinemia, Primary Biliary Cholangitis (PBC), transaminitis

Abstract

Jaundice, characterized by yellow discoloration of the skin, mucous membranes, and sclera, results from hyperbilirubinemia and is uncommon in adults. Its occurrence often signals serious underlying conditions. Hyperbilirubinemia may also present with cutaneous manifestations, including xerosis, hyperpigmented plaques, and erythematous rashes. A 47-year-old woman presented with hyperbilirubinemia, transaminitis, and cutaneous manifestations, including hyperpigmented plaques on the face, erythematous rashes on the hands and feet, and yellowish discoloration of the skin. Despite extensive evaluation, including viral hepatitis screening, autoimmune markers, and imaging, a definitive diagnosis remained elusive. The clinical features and laboratory findings suggested Primary Biliary Cholangitis (PBC) as the most likely diagnosis, although further confirmation through advanced serological testing and liver biopsy was needed. Treatment with ursodeoxycholic acid (UDCA) and high-dose oral methylprednisolone showed clinical improvement but persisted in transaminitis with a normal ultrasonographic appearance. This case emphasizes the importance of recognizing cutaneous signs in systemic diseases and the need for a comprehensive diagnostic approach in resource-limited settings.

References

Fargo MV, Grogan SP, Saguil A. Evaluation of jaundice in adults. Am Fam Physician. 2017;95(3):164-8.

Godara S, Thappa D, Pottakkatt B, et al. Cutaneous manifestations in disorders of the hepatobiliary system. Indian Dermatol Online J. 2017;8(1):9. doi:10.4103/2229-5178.198760

Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024;404(10457):1053-66. doi:10.1016/S0140-6736(24)01303-5

Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and management of primary billiary cholangitis. American Journal of Gastroenterology. 2019;114(1):48-63. doi:10.1038/s41395-018-0390-3

Hirschfield GM, Dyson JK, Alexander GJM, et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018;67(9):1568-94. doi:10.1136/gutjnl-2017-315259

Boonstra, Kirsten, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. Journal of Hepatology. 2012;56(5) 1181-1188.

Ma D, Ma J, Zhao C, Tai W. Reasons why women are more likely to develop primary biliary cholangitis. Heliyon. 2024;10(4):e25634. doi:10.1016/j.heliyon.2024.e25634

Brkić M. The role of E2/P ratio in the etiology of fibrocystic breast disease, mastalgia, and mastodynia. Acta Clin Croat. Published online in 2018. doi:10.20471/acc.2018.57.04.18

Purohit T. Primary biliary cirrhosis: Pathophysiology, clinical presentation, and therapy. World J Hepatol. 2015;7(7):926. doi:10.4254/wjh.v7.i7.926

Chalifoux SL, Konyn PG, Choi G, Saab S. Extrahepatic manifestations of primary biliary cholangitis. Gut Liver. 2017;11(6):771-780. doi:10.5009/gnl16365

Terziroli Beretta-Piccoli B, Guillod C, Marsteller I, et al. Primary biliary cholangitis associated with skin disorders: A case report and review of the literature. Arch Immunol Ther Exp (Warsz). 2017;65(4):299-309. doi:10.1007/s00005-016-0448-0

Koulentaki M, Ioannidou D, Stefanidou M, et al. Dermatological manifestations in primary billiary cirrhosis patients: A case-control study. Am J Gastroenterol. 2006;101(3):541-6. doi:10.1111/j.1572-0241.2006.00423.x

Zhang Y, Zheng T, Huang Z, Song B. CT and MR imaging of primary biliary cholangitis: a pictorial review. Insights Imaging. 2023;14(1):180. doi:10.1186/s13244-023-01517-3

Barba Bernal R, Ferrigno B, Morales EM, et al. Management of primary biliary cholangitis: Current treatment and future perspectives. The Turkish Journal of Gastroenterology. 2023;34(2):89-100. doi:10.5152/tjg.2023.22239

van Hooff MC, Werner E, van der Meer AJ. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid. Eur J Intern Med. 2024;124:14-21. doi:10.1016/j.ejim.2024.01.030

Marchioni Beery RM VHFF. Primary biliary cirrhosis and primary sclerosing cholangitis: a review featuring a women’s health perspective. J Clin Transl Hepatol. 2014;2(4). doi:10.14218/JCTH.2014.00024

Downloads

Published

2025-10-03

How to Cite

Supriono, S., Safira, Z., Budiarto, A. A., Fachrureza, M., Mustika, S., & Wibowo, B. P. (2025). Hyperbilirubinemia with Unusual Dermatologic Signs: A Diagnostic Puzzle. Acta Medica Indonesiana, 57(3), 380. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/2948